Ali Asghar Ebrahimi

A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis

Ahmadreza Jamshidi, Farhad Gharibdoost, Mahdi Vojdanian et al. · Arthritis Research & Therapy · 2017 · 33 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Serum levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in treated rheumatoid arthritis patients.

Ali Asghar Ebrahimi, Hamid Noshad, Shahram Sadreddini et al. · PubMed · 2009 · 30 citations

Life Sciences, Immunology, Internal Medicine +13

A Pilot Study of Potassium Supplementation in the Treatment of Hypokalemic Patients With Rheumatoid Arthritis: A Randomized, Double-Blinded, Placebo-Controlled Trial

Reza Rastmanesh, Amin Salehi‐Abargouei, Zhaleh Shadman et al. · Journal of Pain · 2008 · 25 citations

Medicine, Clinical Sciences, Internal Medicine +16

Association analysis of ERAP1 gene single nucleotide polymorphism in susceptibility to ankylosing spondylitis in Iranian population

Farhad Babaie, Mehrdad Ebrazeh, Maryam Hemmatzadeh et al. · Immunology Letters · 2018 · 21 citations

Life Sciences, Genetics, Molecular Genetics +11

Evaluation of ERAP1 Gene Single Nucleotide Polymorphism in Impressing the Inflammatory Cytokine Profile of Ankylosing Spondylitis Patients

Hamed Mohammadi, Farhad Babaie, Maryam Hemmatzadeh et al. · Iranian Journal of Allergy Asthma and Immunology · 2018 · 16 citations · Full text

Life Sciences, Genetics, Immunology +16